These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31421198)

  • 1. Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry.
    Gheibi Hayat SM; Bianconi V; Pirro M; Sahebkar A
    Int J Pharm; 2019 Oct; 569():118628. PubMed ID: 31421198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD47 Functionalization of Nanoparticles as a Poly(ethylene glycol) Alternative: A Novel Approach to Improve Drug Delivery.
    Vandchali NR; Moadab F; Taghizadeh E; Tajbakhsh A; Gheibihayat SM
    Curr Drug Targets; 2021; 22(15):1750-1759. PubMed ID: 33563192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome Circulation Time is Prolonged by CD47 Coating.
    Hayat SMG; Jaafari MR; Hatamipour M; Penson PE; Sahebkar A
    Protein Pept Lett; 2020; 27(10):1029-1037. PubMed ID: 32282292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Blood Cell Membrane as a Biomimetic Nanocoating for Prolonged Circulation Time and Reduced Accelerated Blood Clearance.
    Rao L; Bu LL; Xu JH; Cai B; Yu GT; Yu X; He Z; Huang Q; Li A; Guo SS; Zhang WF; Liu W; Sun ZJ; Wang H; Wang TH; Zhao XZ
    Small; 2015 Dec; 11(46):6225-36. PubMed ID: 26488923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-target and direct modulation of alloreactive T cells by a nanoparticle carrying MHC alloantigen, regulatory molecules and CD47 in a murine model of alloskin transplantation.
    Shahzad KA; Wan X; Zhang L; Pei W; Zhang A; Younis M; Wang W; Shen C
    Drug Deliv; 2018 Nov; 25(1):703-715. PubMed ID: 29508634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of CD47-modified biomaterials to mitigate the immune response.
    Tengood JE; Levy RJ; Stachelek SJ
    Exp Biol Med (Maywood); 2016 May; 241(10):1033-41. PubMed ID: 27190273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Biomimetic Copper Sulfide Nanozyme Mediates "Don't Eat Me" Signaling for Photothermal and Chemodynamic Precision Therapies of Breast Cancer.
    Zhan Z; Zeng W; Liu J; Zhang L; Cao Y; Li P; Ran H; Wang Z
    ACS Appl Mater Interfaces; 2023 May; 15(20):24071-24083. PubMed ID: 37159843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescent and mass spectrometric evaluation of the phagocytic internalization of a CD47-peptide modified drug-nanocarrier.
    Liu C; Yu D; Ge F; Yang L; Wang Q
    Anal Bioanal Chem; 2019 Jul; 411(18):4193-4202. PubMed ID: 31093697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises.
    Tong B; Wang M
    Future Oncol; 2018 Sep; 14(21):2179-2188. PubMed ID: 29667847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stealth Coating of Nanoparticles in Drug-Delivery Systems.
    Fam SY; Chee CF; Yong CY; Ho KL; Mariatulqabtiah AR; Tan WS
    Nanomaterials (Basel); 2020 Apr; 10(4):. PubMed ID: 32325941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD47-SIRPα signaling axis as an innate immune checkpoint in cancer.
    Matlung HL; Szilagyi K; Barclay NA; van den Berg TK
    Immunol Rev; 2017 Mar; 276(1):145-164. PubMed ID: 28258703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking CD47 with restructured peptide nanoparticles for motivating phagocytosis to inhibit tumor progression.
    Xia Y; Wang T; Wu L; Zhong H; Zhou Y; Ke P; Bao X; Dai Q; Yang Q; Lu Y; Xu D; Liang M; Han M
    Biomater Sci; 2022 Jul; 10(15):4324-4334. PubMed ID: 35775458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunotherapy targeting the CD47/SIRPα axis.
    Weiskopf K
    Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD47 Enhances In Vivo Functionality of Artificial Antigen-Presenting Cells.
    Bruns H; Bessell C; Varela JC; Haupt C; Fang J; Pasemann S; Mackensen A; Oelke M; Schneck JP; Schütz C
    Clin Cancer Res; 2015 May; 21(9):2075-83. PubMed ID: 25593301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimal "Self" peptides that inhibit phagocytic clearance and enhance delivery of nanoparticles.
    Rodriguez PL; Harada T; Christian DA; Pantano DA; Tsai RK; Discher DE
    Science; 2013 Feb; 339(6122):971-5. PubMed ID: 23430657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD47 Blockade Inhibits Tumor Progression through Promoting Phagocytosis of Tumor Cells by M2 Polarized Macrophages in Endometrial Cancer.
    Gu S; Ni T; Wang J; Liu Y; Fan Q; Wang Y; Huang T; Chu Y; Sun X; Wang Y
    J Immunol Res; 2018; 2018():6156757. PubMed ID: 30525058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells.
    Piccione EC; Juarez S; Tseng S; Liu J; Stafford M; Narayanan C; Wang L; Weiskopf K; Majeti R
    Clin Cancer Res; 2016 Oct; 22(20):5109-5119. PubMed ID: 27126995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway.
    Matozaki T; Murata Y; Okazawa H; Ohnishi H
    Trends Cell Biol; 2009 Feb; 19(2):72-80. PubMed ID: 19144521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release.
    Lian S; Xie R; Ye Y; Xie X; Li S; Lu Y; Li B; Cheng Y; Katanaev VL; Jia L
    EBioMedicine; 2019 Apr; 42():281-295. PubMed ID: 30878596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.